Search results
Capricor Therapeutics Inc (CAPR) Reports Encouraging Year-End Financials and Advances in DMD Therapy
GuruFocus.com via Yahoo Finance· 3 months agoRevenue Growth: Q4 revenue soared to $12.1 million, a significant increase from $1.0 million in Q4...
Sarepta's (SRPT) DMD Gene Therapy Gets Endorsed by FDA Panel
Zacks via Yahoo Finance· 1 year agoThe FDA's CTGTAC narrowly recommends granting accelerated approval to Sarepta's (SRPT) DMD gene...
Sarepta's (SRPT) DMD Drug sBLA Gets FDA's Priority Tag, Stock Up
Zacks via Yahoo Finance· 4 months agoSarepta (SRPT) announces the FDA's acceptance of its efficacy supplement to the Elevidys BLA,...
Sarepta (SRPT) Seeks FDA Nod for DMD Gene Therapy Candidate
Zacks via Yahoo Finance· 2 years agoIf approved, Sarepta's (SRPT) SRP-9001 will be the first gene therapy for DMD indication in the...
Biotech Stock Roundup: SRPT's DMD Therapy Approval, ICPT's Setback & More Updates
Zacks via Yahoo Finance· 11 months agoIt was a busy week for the biotech sector. Key regulatory and pipeline updates from Sarepta...
Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
Zacks via Yahoo Finance· 6 months agoSolid Biosciences (SLDB) gains 68% as the FDA grants Fast Track designation to the company's gene...
Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera
Zacks via Yahoo Finance· 12 months agoCatalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North...
Sarepta (SRPT) Down on Clinical Hold on DMD Candidate SRP-5051
Zacks via Yahoo Finance· 2 years agoThe FDA places Sarepta's (SRPT) next-generation DMD candidate, SRP-5051, on clinical hold, following...
Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
Zacks via Yahoo Finance· 2 months agoSolid Biosciences' (SLDB) novel gene-therapy candidate, SGT-003, gets FDA's Rare Pediatric Disease...
REGENXBIO (RGNX) Soars 15% on Interim Data From DMD Study
Zacks via Yahoo Finance· 3 months agoData from an early-stage study shows that treatment with REGENXBIO's (RGNX) investigational Duchenne...